Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

18.05.2026

2 AIDS
1 AIDS Res Hum Retroviruses
2 Antivir Ther
1 BMJ
1 Br J Dermatol
4 Clin Infect Dis
3 HIV Med
1 J Infect Dis
1 J Med Virol
3 J Virol
1 Lancet
3 Lancet Infect Dis
3 N Engl J Med
1 Pediatr Infect Dis J
9 PLoS One
1 PLoS Pathog
1 Science
1 Vaccine



    AIDS

  1. BENZEKRI NA, Plaisy MK, Koffi JJ, Mensah E, et al
    Food insecurity and cardiometabolic diseases among people with HIV in West Africa.
    AIDS. 2026 May 12. doi: 10.1097/QAD.0000000000004541.
    >> Share

  2. CHAUHAN L, Wu K, Tassiopoulos K, Rubin LH, et al
    Effect of hospitalization on cognitive and physical function in people with HIV.
    AIDS. 2026 May 4. doi: 10.1097/QAD.0000000000004532.
    >> Share


    AIDS Res Hum Retroviruses

  3. CAO Y, Zang S, Du J, Li S, et al
    Genomic Characterization of Two Novel Human Immunodeficiency Virus-1 Recombinant Forms (CRF01_AE and B) in Men Who Have Sex with Men in Hebei, China.
    AIDS Res Hum Retroviruses. 2026 May 12:8892229261451042.
    >> Share


    Antivir Ther

  4. EFRIDA, Yuza A
    Factors associated with immunological non-response in HIV patients receiving antiretroviral therapy in Southeast Asia: A systematic review.
    Antivir Ther. 2026;31:13596535261450699.
    >> Share

  5. PANNECOUCKE C, Valin N, Peytavin G, Lambert S, et al
    Safety and efficacy of deltoid intramuscular long-acting cabotegravir and rilpivirine, a case series.
    Antivir Ther. 2026;31:13596535261436877.
    >> Share


    BMJ

  6. NEJADGHADERI SA, Razai MS, Sharifi H, Harandi MF, et al
    The US-Israeli war is driving a displacement crisis in Iran.
    BMJ. 2026;393:s879.
    >> Share


    Br J Dermatol

  7. EL BANNA G, Wishner S, Baker N, Peacker BL, et al
    Risk of skin and subcutaneous diseases in paediatric HIV-exposed uninfected individuals in the United States.
    Br J Dermatol. 2026 May 11:ljag144. doi: 10.1093.
    >> Share


    Clin Infect Dis

  8. MOODY K, Vanbellinghen MC, Nieuwkerk PT, Boyd A, et al
    Health-related quality of life in well-treated people with HIV and comparators over an 8-year period: a longitudinal analysis from the prospective AGEhIV cohort study.
    Clin Infect Dis. 2026 May 14:ciag281. doi: 10.1093.
    >> Share

  9. FAMIGLIETTI AM, Drammeh S, Vo-Quang E, Dibba B, et al
    Field performance and acceptability of the hepatitis B core-related antigen rapid diagnostic test (HBcrAg-RDT) for detecting high viral load among pregnant women in The Gambia (PROTECT-B).
    Clin Infect Dis. 2026 May 12:ciag311. doi: 10.1093.
    >> Share

  10. PUGSLEY RA, Davis NL, Barbee LA
    Is one all we really need? Reply to Lorenz et al regarding shorter duration of benzathine penicillin G therapy for late or unknown duration syphilis.
    Clin Infect Dis. 2026 May 13:ciag299. doi: 10.1093.
    >> Share

  11. SABIN CA
    Does HIV infection continue to contribute to poorer health-related quality of life?
    Clin Infect Dis. 2026 May 14:ciag282. doi: 10.1093.
    >> Share


    HIV Med

  12. YEUNG A, Estcourt C, Cullen B, Metcalfe R, et al
    Sustained effect of Scotland's HIV pre-exposure prophylaxis programme on transmission among gay and bisexual men who have sex with men: Population-based retrospective cohort study.
    HIV Med. 2026 May 8. doi: 10.1111/hiv.70255.
    >> Share

  13. LI X, Li K, Li Y, Zhao Y, et al
    Diabetes risk in HIV infection and antiretroviral therapy: A systematic review and meta-analysis of prospective cohort evidence.
    HIV Med. 2026 May 10. doi: 10.1111/hiv.70256.
    >> Share

  14. MERLIN C, Damas J, Tshikung ON, Wagner N, et al
    CHildren of the Cohort Study (CHOC): Exploring parenting desire among people living with HIV in Switzerland.
    HIV Med. 2026 May 11. doi: 10.1111/hiv.70253.
    >> Share


    J Infect Dis

  15. SBARRA AN, Stone W, Tetteh K, Ssewanyana I, et al
    Assessing the effect of malaria exposure history on tetanus antibody waning rates among children in Jinja and Tororo Districts, Uganda.
    J Infect Dis. 2026 May 9:jiag255. doi: 10.1093.
    >> Share


    J Med Virol

  16. DYER CEF, Molano M, Roberts JM, Yang T, et al
    Causative Human Papillomavirus (HPV) Genotypes of Anal Cancers in Australian Cisgender Women.
    J Med Virol. 2026;98:e70957.
    >> Share


    J Virol

  17. MARTRES D, Montagne T, Pani S, Jeanne N, et al
    Genotypic and phenotypic characteristics of CXCR4-using transmitted/founder HIV-1 envelope glycoproteins.
    J Virol. 2026 May 14:e0006726. doi: 10.1128/jvi.00067.
    >> Share

  18. SHI H, Quan P, Hou Y, Wang H, et al
    TRIP12 promotes HIV-1 replication and latency reactivation by stabilizing Tat via USP7-mediated deubiquitination.
    J Virol. 2026 May 13:e0039626. doi: 10.1128/jvi.00396.
    >> Share

  19. VINZANT K, Cheshenko N, Pan H, Cutler R, et al
    A cell-impermeable kinase inhibitor uncovers outside-in signaling pathways that promote HIV-1 infection.
    J Virol. 2026 May 11:e0016026. doi: 10.1128/jvi.00160.
    >> Share


    Lancet

  20. MENDELSON M, Brink A
    Emerging beta-lactam and beta-lactamase inhibitor strategies for complicated urinary tract infections.
    Lancet. 2026;407:1893-1895.
    >> Share


    Lancet Infect Dis

  21. COSSA M, Ndege R, Meggi B, Mangu C, et al
    Expanding Xpert MTB/RIF Ultra and lateral flow urine lipoarabinomannan testing for diagnosis of tuberculosis among adults living with HIV admitted to hospitals in Tanzania and Mozambique (EXULTANT): a randomised controlled trial.
    Lancet Infect Dis. 2026 May 6:S1473-3099(26)00133.
    >> Share

  22. YECHEZKEL M, Helekal D, Kapadia B, Hong V, et al
    Durability of doxycycline effectiveness against gonorrhoea after implementation of post-exposure prophylaxis in southern California, USA: a retrospective, test-negative, observational study.
    Lancet Infect Dis. 2026 May 7:S1473-3099(26)00123.
    >> Share

  23. SEGIL J, Mimiaga MJ
    Actionable sexual health education for HIV and STI prevention among LGBTQ+ youth in the USA.
    Lancet Infect Dis. 2026 May 12:S1473-3099(26)00225.
    >> Share


    N Engl J Med

  24. HAYDEN FG, Shinkai M, Clark TW, Luetkemeyer AF, et al
    Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts.
    N Engl J Med. 2026;394:1905-1915.
    >> Share

  25. OLALLA J
    Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges.
    N Engl J Med. 2026;394:1963.
    >> Share

  26. RANA AI, Castillo-Mancilla J, Landovitz RJ
    Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges. Reply.
    N Engl J Med. 2026;394:1963-1964.
    >> Share


    Pediatr Infect Dis J

  27. MARIN M, Raparti L, Leung J, Oliver SE, et al
    Safety and Immunogenicity of Varicella Vaccination in Children and Adolescents Living With HIV: A Systematic Review.
    Pediatr Infect Dis J. 2026 May 11. doi: 10.1097/INF.0000000000005264.
    >> Share


    PLoS One

  28. DOMINGUEZ-CASTRO M, Ramirez-Ramirez A, Plazola-Camacho NG, Avila-Garcia M, et al
    Quality of life in the postpartum period of Mexican women living with HIV: The role of clinical and sociodemographic factors.
    PLoS One. 2026;21:e0330790.
    >> Share

  29. CHAMBERLIN S
    Educational attainment and chronic HIV treatment adherence in southern and eastern Africa.
    PLoS One. 2026;21:e0348947.
    >> Share

  30. LI Y, Wu C, Yu L, Shi H, et al
    Constructing HIV/AIDS in Chinese media (2010-2024): A mixed-methods study.
    PLoS One. 2026;21:e0349242.
    >> Share

  31. MARBAN-CASTRO E, Thomas C, Nikitin D, Thomas C, et al
    Key populations and healthcare providers perceptions, preferences and acceptability of HIV, Hepatitis B and C multiplex self-testing: A qualitative study.
    PLoS One. 2026;21:e0346601.
    >> Share

  32. AGRAWAL P, Yadav R, Madhumalar A, Senthil Kumar G, et al
    Phosphorylation landscape of dengue virus proteins and their implications in protein-protein interactions.
    PLoS One. 2026;21:e0345872.
    >> Share

  33. WONGNAAH FG, Eshun G, Akuoko Essuman M, Adu C, et al
    Awareness of and positive attitudes toward HIV pre-exposure prophylaxis among reproductive-aged women in Ghana: A multilevel analysis of the 2022 Demographic and Health Survey.
    PLoS One. 2026;21:e0347111.
    >> Share

  34. DZRAMADO VL, Lasim OU, Oduro E
    Translating research into action: Policy recommendations for strengthening antiretroviral therapy adherence in Ghana based on empirical evidence.
    PLoS One. 2026;21:e0344395.
    >> Share

  35. SOTO L, Sulbaran YF, Jaspe RC, Urena F, et al
    A snapshot of HIV-1 genetic diversity in Dominican Republic in 2024: Predominance of the BCar lineage and first description of a CRF02-AG isolate.
    PLoS One. 2026;21:e0348313.
    >> Share

  36. KUSEMERERWA S, Kansiime S, Mutonyi G, Kakande A, et al
    Estimating HIV incidence and assessing associated risk factors among adults: Evidence from the 2018-2022 HIV vaccine preparedness cohort in Masaka, Uganda.
    PLoS One. 2026;21:e0348769.
    >> Share


    PLoS Pathog

  37. PILLAY M, Choudhary MC, Deo R, Naumenko S, et al
    Extensive diversity and impact of drug-resistant HIV-1 variants in individuals with prior virologic failure.
    PLoS Pathog. 2026;22:e1014118.
    >> Share


    Science

  38. COHEN J
    Trump administration cuts CDC's key role in global program to stop HIV.
    Science. 2026;392:680-681.
    >> Share


    Vaccine

  39. DAGNEW AF, Noble R, Cinar A, Burhan E, et al
    Design and feasibility considerations for a phase 3 efficacy trial of the M72/AS01(E-4) tuberculosis vaccine.
    Vaccine. 2026;85:128690.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016